Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy ; volume:13 ; number:1 ; day:29 ; month:7 ; year:2024 ; pages:1-24 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (29.7.2024), 1-24, 12.2024
- Creator
-
Lau, Kristina
Kotzur, Rebecca
Richter, Franziska
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-024-00430-z
- URN
-
urn:nbn:de:101:1-2410132105548.845872722451
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.04.2025, 8:14 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lau, Kristina
- Kotzur, Rebecca
- Richter, Franziska
- SpringerLink (Online service)
Other Objects (12)
Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier
Microstructural alterations predict impaired bimanual control in Parkinson’s disease
Investigations of Synaptic Alterations in Models of Parkinson’s Disease
Senescence and associated blood–brain barrier alterations in vitro
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Simulating the progression of brain structural alterations in Parkinson’s disease
Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier
Microstructural alterations predict impaired bimanual control in Parkinson’s disease
Investigations of Synaptic Alterations in Models of Parkinson’s Disease
Senescence and associated blood–brain barrier alterations in vitro
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Simulating the progression of brain structural alterations in Parkinson’s disease
Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Treatment of Parkinson’s disease using focused ultrasound with GDNF retrovirus-loaded microbubbles to open the blood–brain barrier
Microstructural alterations predict impaired bimanual control in Parkinson’s disease
Investigations of Synaptic Alterations in Models of Parkinson’s Disease
Senescence and associated blood–brain barrier alterations in vitro
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Simulating the progression of brain structural alterations in Parkinson’s disease
Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability